Design and Synthesis of Statine-Based Cell-Permeable Peptidomimetic Inhibitors of Human β-Secretase
Roy K. Hom(Pfizer (United States)), Varghese John(University of California, Los Angeles), Shumeye Mamo(Pfizer (United States)), Andrea F. Gailunas(Pfizer (United States)), Ashley C. Guinn, Jeroen Knops(Sunesis (United States)), David L. Davis(Sunesis (United States)), Nancy Jewett(Sunesis (United States)), Don E. Walker, John P. Anderson(Sunesis (United States)), Sukanto Sinha(Sunesis (United States)), Jay S. Tung(Sunesis (United States)), Larry Y. Fang(Pfizer (United States)), Eugene D. Thorsett
Cited by 78
Related Papers
Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain
|Journal of Neurochemistry|2001|879
Change in dominance determines herbivore effects on plant biodiversity
|Nature Ecology & Evolution|2018|264
Ayurvedic medicinal plants for Alzheimer's disease: a review
|Alzheimer s Research & Therapy|2012|212
Human β-Secretase (BACE) and BACE Inhibitors
|Journal of Medicinal Chemistry|2003|146